NCT04637087View on ClinicalTrials.gov

Precision Medicine in Ischemic Stroke and Atrial Fibrillation

NACompletedINTERVENTIONAL
Enrollment

805

Participants

Timeline

Start Date

March 11, 2021

Primary Completion Date

March 10, 2022

Study Completion Date

July 14, 2024

Conditions
Atrial FibrillationIschemic Stroke
Interventions
OTHER

Atrial fibrillation risk electronic health record alert

Electronic health record best practice alert which displays patient's 5-year risk of developing atrial fibrillation

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Boston University

OTHER

lead

Massachusetts General Hospital

OTHER

NCT04637087 - Precision Medicine in Ischemic Stroke and Atrial Fibrillation | Biotech Hunter | Biotech Hunter